A twice-daily dose of Celebrex over a period of nine months reduced the incidence of nonmelanoma skin cancer by almost 60 percent, according a new study. Read on..SID: COX-2 Inhibitors May Cut Skin Cancer Rate
Other articles you may be interested in...
- The Truth Behind Opposition of International Prescription Referral Services
- Who’s Behind the Smear Campaign Against Pharmacies Like Planet Drugs Direct
- New Medications Make Significant Impact On Asthma Treatment
- Antidepressant Guide
- Planet Drugs Direct, Who We Are and Why We Might Stop Accepting Credit Cards